MedAssets (MDAS) Reports In-Line Q4 EPS, FY15 EPS Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Intel shares fall as competitor reports record results
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Leerink Swann Downgrades MedAssets (MDAS) to Market Perform
February 18, 2015 7:24 AM ESTLeerink Swann downgraded MedAssets (NASDAQ: MDAS) from Outperform to Market Perform with a price target of $18.00 (from $26.00).
For an analyst ratings summary and ratings history on MedAssets click here. For more ratings news on MedAssets click here.
Shares of MedAssets closed at $19.83 yesterday.
... MoreDeutsche Bank Downgrades MedAssets (MDAS) to Hold
February 18, 2015 6:47 AM ESTDeutsche Bank downgraded MedAssets (NASDAQ: MDAS) from Buy to Hold with a price target of $19.00 (from $23.00). The change follows Q4 results and guidance.
Analyst George Hill said, "MedAssets pre-announced its Q4 results and gave F2015 guidance a week ahead of schedule. Adjusted... More



